| tesaglitazar |
drug |
3 |
3 |
|
| testosterone |
drug |
10 |
8 |
CSF testosterone, androgens, steroid sex hormone testosterone, testosterone, testosterone levels |
| Tet1 |
gene |
3 |
2 |
Tet1, ten-eleven translocation methylcytosine dioxygenase 1 |
| TET2 |
gene |
3 |
3 |
|
| tetrodotoxin |
drug |
5 |
1 |
TTX |
| TF |
gene |
2 |
— |
transcription factor, transferrin |
| TGFB1 |
gene |
7 |
1 |
TGF-beta, TGF-β1, TGFB156, TGFβ, Tgfβ1, Transforming growth factor beta 1 |
| TGF-β |
drug |
5 |
3 |
TGF beta, Transforming growth factor beta, transforming growth factor beta |
| TGFβ |
drug |
7 |
7 |
TGF-beta, TGFB1, Transforming growth factor beta |
| THC |
drug |
8 |
6 |
2.78% THC, CB receptor agonist THC, THC, THC administration, cannabis, delta (9)-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, marijuana, oral THC, oral synthetic THC, tetrahydrocannabinol, Δ-9-tetrahydrocannabinol, Δ9-THC, Δ9-tetrahydrocannabinol, Δ9‑tetrahydrocannabinol |
| The Cancer Genome Atlas |
cohort |
5 |
— |
TCGA |
| Thermo Fisher Scientific |
drug |
9 |
2 |
Thermo Fisher |
| theta activity |
phenotype |
11 |
9 |
EEG theta activity, increased theta activity, primary visual theta, resting θ power, theta EEG activity, theta oscillation, theta rhythm |
| theta band |
phenotype |
21 |
17 |
3.0-7.0 Hz, 4–7 Hz, 4–7 Hz, Theta band, lower theta (4–5 Hz), theta, theta (200-400 ms), theta (4.0-7.5 Hz; 200-400 ms), theta band, theta band (4-7 Hz), theta frequency, theta range, theta rhythm, theta sequences, θ |
| Theta coherence |
phenotype |
2 |
2 |
theta |
| theta ERO |
phenotype |
6 |
6 |
Theta ERO deficits, Theta event-related oscillation, power of theta EROs, theta (4–7 Hz), theta ERO, theta ERO measurements, theta ERO measures, theta ERO power values, theta EROs, theta band ERO, theta event-related oscillation, theta event-related oscillation power, theta event-related oscillations |
| theta EROs |
phenotype |
4 |
4 |
frontal theta event-related oscillations, theta EROs, theta band (4–7 Hz) event‑related oscillations, theta band event-related oscillations, theta event-related oscillations, theta event‑related oscillations |
| theta oscillations |
phenotype |
29 |
26 |
EEG theta activity, absolute theta power, conflict-related theta power, event-related theta, event-related theta oscillations, event-related theta power, hippocampal theta, pre-response theta power, prefrontal theta, reference theta power, relative theta power, response preparation theta power, resting theta power, theta, theta (3.5–7.5 Hz), theta (4–8 Hz), theta ERO, theta activity, theta band, theta band activity, theta band power, theta component of P3 response, theta frequencies, theta oscillation, theta oscillations, theta phase coherence, theta power, theta rhythm, theta rhythms, theta source power, total theta power, θ frequencies, θ power |
| thiamine |
drug |
5 |
2 |
vitamin B, vitamin B1 |
| thiamine deficiency |
drug |
5 |
5 |
enzyme deficiency preventing thiamine use, thiamine-deficiency, thiamine-deficient state |
